Shariqa Aisha
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 14
- Cancer-related Molecular Pathways 7
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Manzoor Ahmad Mir (23 shared papers)Sameer Ullah Khan (3 shared papers)Fayaz Malik (2 shared papers)Umar Mehraj (12 shared papers)Kaneez Fatima (1 shared paper)Shazia Sofi (9 shared papers)Hina Qayoom (7 shared papers)Abdullah Almilaibary (3 shared papers)
- Journals
- Medical Oncology (4 papers)Cell Communication and Signaling (1 paper)IntechOpen eBooks (1 paper)DOAJ (DOAJ: Directory of Open Access Journals) (1 paper)Nova Science Publishers eBooks (5 papers)
- Partner nations
- IndiaSaudi ArabiaUnited States
In The Last Decade
Shariqa Aisha
25 papers receiving 572 citations
Shariqa Aisha's Hit Papers
Peers
Comparison fields: 5 of 63
- Oncology 249
- Cancer Research 115
- Cell Biology 63
- Immunology 77
- Molecular Biology 246
Countries citing papers authored by Shariqa Aisha
This map shows the geographic impact of Shariqa Aisha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shariqa Aisha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shariqa Aisha more than expected).
Fields of papers citing papers by Shariqa Aisha
This network shows the impact of papers produced by Shariqa Aisha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shariqa Aisha. The network helps show where Shariqa Aisha may publish in the future.
Co-authors
The 16 scholars most cited alongside Shariqa Aisha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Unveiling the mechanisms and challenges of cancer drug resistance Hit paper breakdown → | 2024 | 208 |
| 2 | 2022 | 76 | |
| 3 | 2022 | 60 | |
| 4 | 2022 | 44 | |
| 5 | 2022 | 33 | |
| 6 | 2022 | 25 | |
| 7 | 2021 | 16 | |
| 8 | 2021 | 14 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 9 | |
| 13 | 2022 | 8 | |
| 14 | 2022 | 8 | |
| 15 | 2022 | 7 | |
| 16 | 2023 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2022 | 5 |
About Shariqa Aisha
Shariqa Aisha is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 25 papers that have together received 578 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (8 papers), Cancer-related Molecular Pathways (7 papers), Breast Cancer Treatment Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune cells in cancer (3 papers), Microtubule and mitosis dynamics (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Antifungal resistance and susceptibility (2 papers). The work is most often cited by research in Oncology (249 citations), Cancer Research (115 citations), Cell Biology (63 citations), Immunology (77 citations) and Molecular Biology (246 citations). Shariqa Aisha has collaborated with scholars based in India, Saudi Arabia and United States. Frequent co-authors include Manzoor Ahmad Mir, Sameer Ullah Khan, Fayaz Malik, Umar Mehraj, Kaneez Fatima, Shazia Sofi, Hina Qayoom, Abdullah Almilaibary, Mustfa Alkhanani and Syed Mohammed Basheeruddin Asdaq. Their work appears in journals such as Medical Oncology, Cell Communication and Signaling, IntechOpen eBooks, DOAJ (DOAJ: Directory of Open Access Journals) and Nova Science Publishers eBooks.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.